Barclays’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Barclays’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60	Closed	–	–	7294
2016 Q4	$0	Sell	60 -249	-81%	-$1.17K	﹤0.01%	7142
2016 Q3	$1K	Sell	309 -1,690	-85%	-$7.89K	﹤0.01%	6571
2016 Q2	$8K	Buy	+1,999	New	+$7.47K	﹤0.01%	5635
2015 Q4	–	Sell	-2,700	Closed	-$11K	–	7318
2015 Q3	$11K	Buy	2,700 +700	+35%	+$4.52K	﹤0.01%	5759
2015 Q2	$14K	Sell	2,000 -4,986	-71%	-$37.5K	﹤0.01%	5926
2015 Q1	$55K	Buy	6,986 +5,697	+442%	+$48.5K	﹤0.01%	5217
2014 Q4	$12K	Buy	1,289 +534	+71%	+$4.64K	﹤0.01%	6656
2014 Q3	$6K	Buy	755 +380	+101%	+$3.52K	﹤0.01%	7172
2014 Q2	$4K	Sell	375 -147	-28%	-$1.51K	﹤0.01%	7256
2014 Q1	$6K	Buy	522 +219	+72%	+$2.83K	﹤0.01%	7181
2013 Q4	$3K	Buy	303 +164	+118%	+$1.91K	﹤0.01%	7336
2013 Q3	$2K	Sell	139 -63	-31%	-$871	﹤0.01%	7274
2013 Q2	$3K	Buy	+202	New	+$2.6K	﹤0.01%	7507

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Barclays's DSCI Position: Q1 2017 in Review

Barclays sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 60 shares.

Barclays first reported a position in DSCI in Q2 2013 and held it in 13 quarters. The position peaked at $55K in Q1 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Barclays reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Barclays sold 60 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017.
Barclays first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 13 quarters.
Barclays's Derma Sciences, Inc. Common Stock (DE) position peaked at $55K in Q1 2015.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.